Back to search

University of Birmingham

Mycobacterial drug target deconvolution using computational, genetic, phenotypic and proteomic approaches

Abstract

dc:description.abstract

Mycobacterium tuberculosis has burdened humanity for centuries, remains one of the largest global killers, and causes over ten million tuberculosis infections yearly. Resistance to the current treatment regimen is growing and new treatment options are required. Work was undertaken to target the essential M. tuberculosis protein, AroB, and study the mechanism of action of a recently discovered antimycobacterial compound, vanoxerine (GBR12909). Several tools were developed to allow the rapid screening of potential inhibitors against the AroB protein, including biochemical, biophysical, and in vitro assays. Computational screening identified potential inhibitors of AroB, however, no compounds showed activity in vitro or in vivo against AroB or mycobacteria. In contrast, screening a drug repurposing library identified the antimycobacterial activity of vanoxerine, but no known target. Previous work suggested vanoxerine targeted AroB, however, this work has demonstrated it is not the target. Evidence provided herein highlights vanoxerine is a disruptor of the membrane electric potential, with downstream inhibition of efflux and membrane transport. A more potent analogue of vanoxerine was also developed, retaining its mechanism of action, but possessing lower activity against the known human target. Vanoxerine also targeted the pathogenic Enterococcus faecium, suggesting routes for future development against multiple pathogenic species. Overall, this work provides a strong foundation for future drug discovery studies targeting M. tuberculosis.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kingdon, Alexander David Harry
ORCID person:identifier.orcid

Subjects

dc:subject × 3

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
Wellcome Trust Doctoral Training Program Antimicrobials and Antimicrobial Resistance
108876/B/15/Z

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Kingdon, Alexander David Harry. Mycobacterial drug target deconvolution using computational, genetic, phenotypic and proteomic approaches. d_ph thesis, University of Birmingham, 2023.